Alain Patat Selected Research

2- cyclohexylidenhydrazo- 4- phenyl- thiazole

4/2000

Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alain Patat Research Topics

Disease

3	Infections 01/2018 - 06/2011
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2005 - 07/2001
2	Fragile X Syndrome (Martin Bell Syndrome) 05/2022 - 10/2021
2	Chronic Hepatitis C 08/2011 - 06/2011
2	Ankylosing Spondylitis 11/2004 - 05/2004
2	Psoriatic Arthritis 11/2004 - 05/2004
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2004 - 05/2004
2	Rheumatoid Arthritis 11/2004 - 05/2004
1	Intellectual Disability (Idiocy) 05/2022
1	Channelopathies 05/2022
1	Autism Spectrum Disorder 05/2022
1	Photophobia (Light Sensitivity) 05/2022
1	Autistic Disorder (Autism) 05/2022
1	Fibrosis (Cirrhosis) 01/2018
1	Osteoporosis 01/2018
1	Schizophrenia (Dementia Praecox) 01/2016
1	Parkinson Disease (Parkinson's Disease) 11/2015
1	Prostatic Neoplasms (Prostate Cancer) 07/2015
1	Breast Neoplasms (Breast Cancer) 07/2015
1	Onchocerciasis 01/2012
1	Hepatitis C 08/2011
1	Injection Site Reaction 05/2011
1	Autoimmune Diseases (Autoimmune Disease) 05/2011
1	Headache (Headaches) 01/2010
1	Alzheimer Disease (Alzheimer's Disease) 03/2009
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2008
1	Chronic Disease (Chronic Diseases) 01/2005
1	Sleep Wake Disorders 01/2005
1	Hip Fractures (Intertrochanteric Fractures) 01/2005
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2004
1	Ascites 11/2002
1	Hyponatremia 11/2002
1	Sleepiness 04/2000
1	Sleep Deprivation 04/2000

Drug/Important Bio-Agent (IBA)

3	Antiviral Agents (Antivirals)IBA 01/2018 - 06/2011
3	Hypnotics and Sedatives (Sedatives)IBA 01/2005 - 07/2001
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2021
2	Pharmaceutical PreparationsIBA 01/2018 - 03/2008
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2004
2	danoprevirIBA 08/2011 - 06/2011
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2004 - 05/2004
2	Etanercept (Enbrel)FDA Link 11/2004 - 05/2004
1	Retinaldehyde (Retinal)IBA 05/2022
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 05/2022
1	CalciumIBA 05/2022
1	PotassiumIBA 05/2022
1	NucleotidesIBA 01/2018
1	bazedoxifeneIBA 01/2018
1	adafosbuvirIBA 01/2018
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	opicaponeIBA 11/2015
1	Levodopa (L Dopa)FDA LinkGeneric 11/2015
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 11/2015
1	onapristoneIBA 07/2015
1	Antiparasitic Agents (Antiparasitics)IBA 01/2012
1	moxidectinIBA 01/2012
1	InterferonsIBA 08/2011
1	Ribavirin (Virazole)FDA LinkGeneric 08/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 06/2011
1	Viral RNAIBA 06/2011
1	PI 2301IBA 05/2011
1	Immunologic Factors (Immunomodulators)IBA 05/2011
1	Amino Acids FDA Link 05/2011
1	Bosentan (Tracleer)FDA Link 01/2010
1	EnzymesIBA 01/2010
1	lecozotanIBA 03/2009
1	Sirolimus (Rapamycin)FDA Link 03/2008
1	Vasopressins (Vasopressin)IBA 11/2002
1	zaleplon (Sonata)FDA LinkGeneric 02/2002
1	Caffeine (No Doz)FDA LinkGeneric 04/2000
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2000

Therapy/Procedure

2	Therapeutics 11/2015 - 08/2011
1	Subcutaneous Injections 05/2011
1	Drug Tapering 03/2008